Amy Coon

935 total citations
8 papers, 782 citations indexed

About

Amy Coon is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Amy Coon has authored 8 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Organic Chemistry and 1 paper in Genetics. Recurrent topics in Amy Coon's work include Redox biology and oxidative stress (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Amy Coon is often cited by papers focused on Redox biology and oxidative stress (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Amy Coon collaborates with scholars based in United States. Amy Coon's co-authors include Garth Powis, Debbie J. Mustacich, Daruka Mahadevan, Emmanuelle J. Meuillet, Margareta Berggren, Amanda F. Baker, Chris A. Pritsos, Abby C. Collier, Ryan G. Snodgrass and Ryan Williams and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Amy Coon

8 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Coon United States 8 656 78 77 64 63 8 782
Sarita G. Menon United States 10 455 0.7× 52 0.7× 44 0.6× 92 1.4× 49 0.8× 12 699
John A. Hinks United Kingdom 5 751 1.1× 115 1.5× 69 0.9× 62 1.0× 57 0.9× 5 901
Eli Oldham United States 2 452 0.7× 44 0.6× 96 1.2× 133 2.1× 57 0.9× 7 757
Toshiya Tamura Japan 19 559 0.9× 74 0.9× 154 2.0× 90 1.4× 34 0.5× 53 969
Carol A. Chrestensen United States 15 772 1.2× 91 1.2× 29 0.4× 107 1.7× 76 1.2× 23 1.0k
Katriina Kahlos Finland 19 649 1.0× 136 1.7× 78 1.0× 193 3.0× 84 1.3× 24 1.1k
Roberto Jun Arai Brazil 9 487 0.7× 102 1.3× 28 0.4× 71 1.1× 58 0.9× 10 641
Olivier Morand Switzerland 16 365 0.6× 83 1.1× 110 1.4× 43 0.7× 45 0.7× 27 730
Nathaniel Edward Bennett Saidu France 17 372 0.6× 34 0.4× 124 1.6× 65 1.0× 33 0.5× 24 774
Gregory F. Davis United States 9 336 0.5× 49 0.6× 34 0.4× 53 0.8× 44 0.7× 14 590

Countries citing papers authored by Amy Coon

Since Specialization
Citations

This map shows the geographic impact of Amy Coon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Coon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Coon more than expected).

Fields of papers citing papers by Amy Coon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Coon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Coon. The network helps show where Amy Coon may publish in the future.

Co-authorship network of co-authors of Amy Coon

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Coon. A scholar is included among the top collaborators of Amy Coon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Coon. Amy Coon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Snodgrass, Ryan G., Abby C. Collier, Amy Coon, & Chris A. Pritsos. (2010). Mitomycin C Inhibits Ribosomal RNA. Journal of Biological Chemistry. 285(25). 19068–19075. 51 indexed citations
2.
Kim, Yon Hui, Amy Coon, Amanda F. Baker, & Garth Powis. (2010). Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. Cancer Chemotherapy and Pharmacology. 68(2). 405–413. 38 indexed citations
3.
Baker, Amanda F., Terry H. Landowski, Robert T. Dorr, et al.. (2007). The Antitumor Agent Imexon Activates Antioxidant Gene Expression: Evidence for an Oxidative Stress Response. Clinical Cancer Research. 13(11). 3388–3394. 17 indexed citations
4.
Meuillet, Emmanuelle J., Daruka Mahadevan, Margareta Berggren, Amy Coon, & Garth Powis. (2004). Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Archives of Biochemistry and Biophysics. 429(2). 123–133. 160 indexed citations
5.
Meuillet, Emmanuelle J., Nathan T. Ihle, Amanda F. Baker, et al.. (2004). In Vivo Molecular Pharmacology and Antitumor Activity of the Targeted Akt Inhibitor PX-316. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 14(10). 513–527. 46 indexed citations
6.
Meuillet, Emmanuelle J., Daruka Mahadevan, Hariprasad Vankayalapati, et al.. (2003). Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues.. PubMed. 2(4). 389–99. 71 indexed citations
7.
Dvořáková, Kateřina, Claire M. Payne, Margaret E. Tome, et al.. (2002). Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.. PubMed. 1(3). 185–95. 29 indexed citations
8.
Powis, Garth, Debbie J. Mustacich, & Amy Coon. (2000). The role of the redox protein thioredoxin in cell growth and cancer. Free Radical Biology and Medicine. 29(3-4). 312–322. 370 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026